Module Expansion Inovus has released two new laparoscopic modules for its LapAR platform the Mesocolic Dissection Model and the Cholecystectomy Model, along with expanded general surgery modules. This signals growing demand for versatile laparoscopic and general surgery simulation in training programs, clinics, and universities, creating opportunities to sell complete LapAR module bundles and expand into general surgery curricula.

Strategic Partnerships A December 2025 global strategic partnership with UpSurgeOn strengthens international distribution and co-development potential. Coupled with the ERIC Education, Research Innovation Centre, Inovus can offer integrated training facilities and turnkey simulation labs to hospitals and medical schools, enabling rapid scale through partner networks.

Funding and Adoption Inovus engagement with local government funding and investment, evidenced by LCR Innovation Zone financing and participation in LCR Ignite, creates openings to align with funded education initiatives and grant-backed lab deployments, accelerating adoption in regional training centers and academic settings.

Value Proposition As a compact, venture-backed supplier using additive manufacturing to deliver affordable, accessible simulation, Inovus positions itself as a cost-effective alternative to larger competitors for medical schools, residency programs, and community hospitals seeking high-fidelity training with synthetic organ realism in ERIC labs.

Lead Gen Channels The company already uses digital channels such as Google Ads, LinkedIn tags, and Squarespace; this presents a ready-made path for targeted outreach to surgical educators, simulation centers, and procurement teams. Focused campaigns around LapAR modules, soft tissue updates, and ERIC offerings can build a consistent sales pipeline.